Karen Sims serves as Executive at Arbutus Biopharma Corp, where they oversee executive responsibilities. Since joining the company, Karen Sims has executed 2 insider transactions totaling $10.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2024 involved selling 4,358 shares valued at $10.1K.
Karen Sims currently holds 125,542 shares of Arbutus Biopharma Corp (ABUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen Sims has been a net seller of ABUS stock. They have purchased $0 and sold $10.1K worth of shares.
Karen Sims's most recent insider trade was on Feb 2, 2024, when they sold 4,358 shares at $2.31 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Planned |